ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
February 03, 2021Agenus has entered into a clinical collaboration with Nelum to evaluate the safety and efficacy of zalifrelimab, Agenus’ anti-CTLA-4 antibody, in combination with NLM-001, Nelum’s small molecule hedgehog inhibitor, and chemotherapy for first-line ... -
Immunotherapies to treat cervical cancer show promise in Phase II trials
October 16, 2020Novel programmed cell death protein 1 immunotherapies for cervical cancer have demonstrated success in two Phase II clinical trials in the US. -
Agenus Receives Fast Track Designation for Cervical Cancer Treatment
March 17, 2020Agenus announced the U.S. Food and Drug Administration (FDA) has granted Agenus Fast Track designation for investigation of balstilimab [PD-1] in combination ...
Pharma Sources Insight January 2025
